How many investments has Allumia Ventures made?

Allumia Ventures has 34 tracked investments, including 3 dated in the last 24 months.

What stage does Allumia Ventures invest at?

Allumia Ventures invests at the Series A, Series B, Series C stages.

What is Allumia Ventures's typical check size?

Allumia Ventures typically writes checks of $5M – $15M.

What sectors does Allumia Ventures focus on?

Allumia Ventures focuses on Digital Health, Enterprise Software, Healthtech, Medical Devices.

Where is Allumia Ventures located?

Allumia Ventures is headquartered in Seattle, US.

Does Allumia Ventures lead rounds?

Yes, Allumia Ventures leads investment rounds.

Allumia Ventures

Venture capital

Seattle · Series A–Series C · 12 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Allumia Ventures

Paths you didn't know you had: your email and LinkedIn already hold routes to the Allumia Ventures team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

Allumia Ventures focuses on driving healthcare innovation. Anchored by Providence and enriched through additional strategic limited partner relationships, the firm expands upon the foundation of Providence Ventures with a broader, more flexible investment model aimed at connecting stakeholders and advancing innovation across the healthcare sector.

Invests inDigital Health Enterprise Software Healthtech Medical Devices Bellevue Seattle United States

Source: firm website, verified Sep 29, 2026.

Leave your own feedback

Stage

Series A–Series C

Check

$5M – $15M

Seattle, Washington, US

Leads rounds

Leads

Instruments

Equity

Founded

2015

Last 12 months

2 investments

AUM

$300M

VC funds

Tracked investments

Team · 12 people

from the firm's website & public directories

Jeff Stolte· Managing Partner

Jeff Stolte is Managing Partner at Allumia Ventures, where he leads healthcare technology investments and manages fund operations. He joined Providence in 2014 as its first VC hire to build and launch Allumia (formerly Providence Ventures), and previously worked as an Investment Manager at Ascension Ventures and within Ascension Health's Strategic Development Group. Earlier he held software product management and business development roles at healthcare technology companies including WebMD, WellMed, and HealthLanguage, and he holds an MBA from the University of Chicago Booth School of Business, an MS in Medical Informatics from Oregon Health & Science University, and an AB from the University of Chicago.

jeff.stolte@providence.org

Branden Fini· Partner· Salt Lake City, Utahin

Branden Fini is a Partner at Allumia Ventures, which he joined in 2019, focusing on healthcare technology and tech-enabled healthcare services. He previously worked at Transformation Capital, Strathspey Crown, and ShoutStore, where he led corporate development. He holds an MBA from The Wharton School and a Mathematics degree from Northwestern University.

branden.fini@providence.org

Dan Galles· Partner· San Francisco Bay Areain

Dan Galles is a Partner at Allumia Ventures, which he joined in 2015, focusing on healthcare information technology, healthcare services, and medical devices. He has more than 20 years of experience backing early- and growth-stage healthcare companies, previously serving as a partner at HLM Venture Partners, an associate at J.H. Whitney and Co., and an analyst in healthcare investment banking at Alex. Brown & Sons. He earned an MBA from Northwestern's Kellogg School and a BS in Economics from The Wharton School.

daniel.galles@providence.org

Christina Warner· Vice President· New York City

Christina Warner joined Allumia Ventures in 2024. She previously worked in healthcare private equity at Thomas H. Lee Partners in Boston and in the Consumer Retail Group at Barclays in New York City. She holds an MBA from Harvard Business School and a degree in Political Science from Brown University.

christina.warner@providence.org

Jen Lee· Vice President· Brooklyn, New Yorkin

Jen Lee joined Allumia Ventures in 2023, where she focuses on healthcare technology and tech-enabled healthcare services. She previously worked at the healthcare and technology private equity firm WCAS in New York and in the Media M&A group at Evercore. She holds an MBA from Harvard Business School and a BS in Finance from the University of Illinois at Urbana-Champaign.

jenny.lee@providence.org

Amber Hill· Project Manager· Bengaluru, Karnataka, Indiain

Amber Hill is the project manager and senior executive assistant at Allumia Ventures, where she handles scheduling and team operations. She previously worked as an executive assistant at Madrona Venture Group and as a corporate operations assistant at F5 Networks, and earlier held roles in property and retail management focused on administration and operations.

Ben Zaniello· Advisor· Park City, Utah, United Statesin

Chief Product and Medical Officer at Best Buy Health; an MD MPH.

Cathy Jacobson· Advisor

Former President and CEO of Froedtert Health and former CFO of Rush Medical.

Craig Slutzkin· CFO· New York City

Craig Slutzkin is the Chief Financial Officer of Allumia Ventures since 2024, overseeing finance, operations, compliance, and human resources. He also serves as COO and CFO of New Leaf Venture Partners, having previously worked at the Sprout Group and spent over seven years in audit and assurance at Arthur Andersen and Ernst & Young. He holds an MBA in Finance from Columbia Business School and a BA in Accounting and Information Systems from Queens College, and is a certified public accountant.

Sandra Clarke· Advisor· Lafayette, California, United Statesin

Former COO and CFO of Blue Shield of California.

Susan Huang· Advisor· United Statesin

Chief Executive Officer of Providence Clinical Network; an MD.

Jeffery J. Stolte· Promoter

What they invest in

from 8 of 34 portfolio companies

Digital Health ×7Healthtech ×6AI & Machine Learning ×3SaaS ×2Cleantech ×1Climate Tech ×1Data & Infrastructure ×1Energy ×1

HQs:United States×7

Investments · 34 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 1 2024 · 1 2018 · 1 2013 · 15 dated

DexCaredexcarehealth.com in✓ verified

DexCare provides patient access and scheduling navigation logic for health systems, enabling patients to find available appointments across multiple care entry points and improving utilization of existing capacity.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSPhiladelphia, US

Sean O'Connor(Co-Founder & President)inMatt Blosl(Chief Executive Officer)inLynne Chou O?Keefe(Director)Aaron Martin(Director)Derek Streat(Executive Officer, Director)

Co-investorsFrist Cressey Ventures ICONIQ TRANSFORMATION CAPITAL Define Ventures Kaiser Permanente Ventures SPRINGROCK VENTURES +2 more

Affect Therapeuticsaffecttherapeutics.com in 𝕏Nov 2025 · $26M

Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.

Digital HealthHealthtechMental HealthNew York, US

Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in

Board Kevin Ryan(Director)in Jeff Rinehart(Director)in

Co-investorsArtis Ventures City Light AlleyCorp Kapor Capital LifeArc Ventures Mana Ventures +2 more

Allumiaallumia.com inJul 2026

Allumia helps utilities design and manage energy efficiency programs from launch through measured results, and helps small and medium-sized businesses cut energy use through lighting, HVAC, and refrigeration upgrades.

CleantechClimate TechEnergyIoTSeattle, US

Aaron Block(Executive Officer, Director)Eyal Levy(Director)

Co-investorsCapital Innovators K Street Capital Skyview Ventures 7wire Ventures

Binary Fountainbinaryfountain.com in 𝕏Dec 2013

Press Ganey (at binaryfountain.com) offers an AI-powered human experience platform for healthcare providers and health plans, using text mining and analytics to turn patient, member, and employee feedback into insights and action plans.

AI & Machine LearningDigital HealthHealthtechMclean, US

Ravi Goplan(Director)Ramu Potarazu(Executive Officer, Director, Promoter)Jitendra Vyas(Executive Officer, Director)Sundeep Damani(Director)Rahul Prakash(Executive Officer, Director)

Co-investorsEscalate Capital Partners HLM Investment Partners Voyager Capital

Greater Good Healthgreatergoodhealth.com in

Greater Good Health provides value-based primary care services for older adults, delivered through nurse practitioners and partnered with health plans, medical groups, and accountable care organizations.

Digital HealthHealthtech

Sylvia Hastanan(Founder)in

Co-investorsEpsilon Health Investors Flare Capital Partners Martin Ventures Optum Ventures Health Velocity Capital LRVHealth

Tailormedtailormed.co in

TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.

Digital HealthHealthtechSaaS

Adam Siton(Founder)inIsrael (Srulik) Dvorsky(Founder)in

Co-investorsAccelmed Partners Ballad Ventures Bridges Israel OSF Ventures Samsung Next Sanara Capital +3 more

Trilliant Healthtrillianthealth.com in 𝕏Jul 2018

Trilliant Health provides analytics, research, and strategic advisory services to stakeholders in the U.S. health economy, helping healthcare decision-makers develop strategies, understand consumer healthcare decisions, and assess return on investment.

AI & Machine LearningData & InfrastructureDigital HealthNashville, US

Hal Andrews(President & Chief Executive Officer)Mark Bacurin(EVP and Chief Financial Officer)inMatt O'Neill(Chief Data Officer and EVP Engineering, Machine Learning, Product)in David Taylor(EVP and Chief Customer Officer)in Josh Saunders(SVP and Chief Technology Officer)in Allison Oakes(VP, Chief Research Officer)in

Co-investorsMartin Ventures Noro-Moseley Partners Primus Capital

Wildflower Healthwildflowerhealth.com inNov 2024

Wildflower Health offers a modular suite of software and services for women's health, combining a digital patient engagement app, a national network of human health advocates and specialists, and value-based care payment model support.

Digital HealthFemTechHealthtechSan Francisco, US

Leah Sparks(CEO & Founder)inKim Russell(Chief Financial Officer of Issuer)in

Board Dan Galles(Director of Issuer)in John Crumpler(Director of Issuer)inEzra Mehlman(Director of Issuer)Ralph Sabin(Director of Issuer)in

Co-investorsEcho Health Ventures Hatteras Venture Partners Healthtech Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Accessible, Compassionate Behavioral HealthBridging Supply and Demand: Right Care, Right TimeClinically Backed Allergen Introduction Platform for InfantsComputer Vision ReimaginedConnecting Healthcare’s Digital EcosystemConsumer-Obsessed Primary CareDemystifying Therapy Costs and OptionsEliminating Preventable BlindnessEmpowering Healthcare to Eliminate RiskEnabling Digital Transformation at Healthcare OrganizationsExample CompanyGamifying Adolescent WellnessHealthcare Data Liquidity at ScaleHuman Experience of HealthcareIdentity-Driven Digital ExperiencesIntelligence for Best-Fit Care OptionsIntelligent Healthcare MarketplaceMaking Musculoskeletal Care Better for EveryoneN Of OneNavigating Complex Healthcare EncountersNext-Generation Chronic Disease ManagementNext-Generation Total Joint Arthroplasty NavigationRedefining care for older adultsRedefining the Meaning of AccessRight-Sized Surgical Devices for True Precision SurgeryThe Future of Healthcare Communication

Portfolio news

latest coverage across their companies

Greater Good Health Closes Series B Funding

Greater Good Health · finsmes.com · Mar 6, 2026

Frequently asked questions

How many investments has Allumia Ventures made?: Allumia Ventures has 34 tracked investments, including 3 dated in the last 24 months.
What stage does Allumia Ventures invest at?: Allumia Ventures invests at the Series A, Series B, Series C stages.
What is Allumia Ventures's typical check size?: Allumia Ventures typically writes checks of $5M – $15M.
What sectors does Allumia Ventures focus on?: Allumia Ventures focuses on Digital Health, Enterprise Software, Healthtech, Medical Devices.
Where is Allumia Ventures located?: Allumia Ventures is headquartered in Seattle, US.
Does Allumia Ventures lead rounds?: Yes, Allumia Ventures leads investment rounds.
Who does Allumia Ventures co-invest with?: Allumia Ventures most often shares deals with Echo Health Ventures, Hatteras Venture Partners, Martin Ventures, among 16 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Don't Miss Tomorrow's #keynote with Branden Fini, Partner at Allumia Ventures! #twh #healthit

This Week Health · Branden Fini

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M